## Abstract Angiotensin II (Ang II) induces, through AT1, intracellular Ca^2+^ increase in both normal and cancerous breast cells in primary culture (Greco et al., 2002 Cell Calcium 2:1–10). We here show that Ang II stimulated, in a dose‐dependent manner, the 24 h‐proliferation of breast cancer cel
Mechanisms of vascular angiotensin II surface receptor regulation by epidermal growth factor
✍ Scribed by Michael E. Ullian; Jerry G. Webb; Ruihua Chen; Richard V. Paul; Thomas A. Morinelli
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 171 KB
- Volume
- 200
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
We investigated mechanisms by which epidermal growth factor (EGF) reduces angiotensin II (AngII) surface receptor density and stimulated actions in vascular smooth muscle cells (VSMC). EGF downregulated specific AngII radioligand binding in intact cultured rat aortic smooth muscle cells but not in cell membranes and also inhibited AngII‐stimulated contractions of aortic segments. Inhibitors of cAMP‐dependent kinases, PI‐3 kinase, MAP kinase, cyclooxygenase, and calmodulin did not prevent EGF‐mediated downregulation of AngII receptor binding, whereas the EGF receptor kinase inhibitor AG1478 did. Total cell AngII AT1a receptor protein content of EGF‐treated and untreated cells, measured by immunoblotting, did not differ. Actinomycin D or cytochalasin D, which interacts with the cytoskeleton, but not the protein synthesis inhibitor cycloheximide, prevented EGF from downregulating AngII receptor binding. Consistently, EGF inhibited AngII‐stimulated formation of inositol phosphates in the presence of cycloheximide but not in the presence of actinomycin D or cytochalasin D. In conclusion, EGF needs an intact signal transduction pathway to downregulate AngII surface receptor binding, possibly by altering cellular location of the receptors. Published 2004 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Previously we found that short peptides surrounding major autophosphorylation sites of EGFR (VPEY^1068^INQ, DY^1148^QQD, and ENAEY^1173^LR) suppress phosphorylation of purified EGFR to 30–50% at 4000 μ__M__. In an attempt to improve potencies of the peptides, we modified the sequences b
GRP78/BiP, a molecular chaperone in the endoplasmic reticulum, is induced under such adverse conditions for cell survival as glucose starvation. Induction of GRP78 has been shown to coincide with G1 cell cycle arrest, which is an important cellular defense system. In this study, we investigated invo
## Abstract In previous studies on HeLa cells we demonstrated estrogen‐responsiveness of the epidermal growth factor receptor (EGFR) gene, as 17β‐estradiol (E~2~) and selective estrogen receptor modulators (SERMs) genistein (G), daidzein (D), and 4‐hydroxytamoxifen (4OH‐T) modulated its transcripti
Epidermal growth factor (EGF) mediates a variety of physiologic responses in rat intestine. EGF receptor (EGFR) responsiveness to EGF is mediated by the surface expression of high affinity EGFR, which is associated with the cytoskeleton (CSK). EGFR signal transduction appears to be mediated by the C